全文获取类型
收费全文 | 26327篇 |
免费 | 2910篇 |
国内免费 | 1035篇 |
专业分类
耳鼻咽喉 | 568篇 |
儿科学 | 183篇 |
妇产科学 | 536篇 |
基础医学 | 2411篇 |
口腔科学 | 475篇 |
临床医学 | 1950篇 |
内科学 | 2158篇 |
皮肤病学 | 293篇 |
神经病学 | 296篇 |
特种医学 | 1504篇 |
外国民族医学 | 38篇 |
外科学 | 4762篇 |
综合类 | 3821篇 |
现状与发展 | 8篇 |
预防医学 | 407篇 |
眼科学 | 191篇 |
药学 | 1070篇 |
5篇 | |
中国医学 | 348篇 |
肿瘤学 | 9248篇 |
出版年
2024年 | 45篇 |
2023年 | 385篇 |
2022年 | 663篇 |
2021年 | 1146篇 |
2020年 | 944篇 |
2019年 | 844篇 |
2018年 | 796篇 |
2017年 | 945篇 |
2016年 | 1064篇 |
2015年 | 1375篇 |
2014年 | 1730篇 |
2013年 | 1536篇 |
2012年 | 1596篇 |
2011年 | 1672篇 |
2010年 | 1464篇 |
2009年 | 1406篇 |
2008年 | 1491篇 |
2007年 | 1438篇 |
2006年 | 1378篇 |
2005年 | 1308篇 |
2004年 | 1080篇 |
2003年 | 983篇 |
2002年 | 823篇 |
2001年 | 666篇 |
2000年 | 625篇 |
1999年 | 517篇 |
1998年 | 477篇 |
1997年 | 359篇 |
1996年 | 259篇 |
1995年 | 233篇 |
1994年 | 193篇 |
1993年 | 129篇 |
1992年 | 118篇 |
1991年 | 82篇 |
1990年 | 73篇 |
1989年 | 63篇 |
1988年 | 60篇 |
1987年 | 50篇 |
1986年 | 36篇 |
1985年 | 41篇 |
1984年 | 39篇 |
1983年 | 26篇 |
1982年 | 23篇 |
1981年 | 30篇 |
1980年 | 25篇 |
1979年 | 15篇 |
1978年 | 11篇 |
1977年 | 5篇 |
1974年 | 2篇 |
1972年 | 1篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
991.
目的研究早期远端胃印戒细胞癌淋巴结转移的危险因素,进一步分析其外科手术指征。方法回顾性分析2013年3月至2018年11月期间在苏州大学附属第一医院普外科接受外科根治手术且术后病理学检查证实为远端胃印戒细胞癌的91例早期胃癌患者的临床资料,收集患者的性别、年龄、肿瘤最大径、病灶数量、浸润深度、肿瘤大体外观、脉管癌栓、合并溃疡等数据,探索发生淋巴结转移的危险因素,进一步分析外科手术指征。结果91例早期远端胃印戒细胞癌均接受了外科根治性手术,其中淋巴结转移10例。单因素分析结果显示,肿瘤最大径(χ^2=5.631,P=0.025)、浸润深度(χ^2=4.389,P=0.016)、病灶数量(χ^2=5.615,P=0.023)及脉管癌栓(χ^2=22.500,P=0.001)均与早期远端胃印戒细胞癌的淋巴结转移有关。多因素分析结果显示,肿瘤最大径(OR=3.675,P=0.012)、浸润深度(OR=3.886,P=0.015)及脉管癌栓(OR=8.711,P<0.001)是早期远端胃印戒细胞癌发生淋巴结转移的影响因素,肿瘤最大径≥2 cm、浸润至黏膜下层及有脉管癌栓的患者有更高的淋巴结转移率。结论肿瘤最大径≥2 cm、浸润至黏膜下层及存在脉管癌栓的早期远端胃印戒细胞癌患者有更高的淋巴结转移风险;满足肿瘤最大径≥2 cm和存在脉管癌栓中任何1项条件者均可能需接受外科根治性手术。 相似文献
992.
993.
994.
995.
996.
997.
Shingo Hatakeyama Shintaro Narita Masahiro Takahashi Toshihiko Sakurai Sadafumi Kawamura Senji Hoshi Masanori Ishida Toshiaki Kawaguchi Shigeto Ishidoya Jiro Shimoda Hiromi Sato Itsuto Hamano Teppei Okamoto Koji Mitsuzuka Akihiro Ito Norihiko Tsuchiya Yoichi Arai Tomonori Habuchi Chikara Ohyama 《International journal of urology》2020,27(7):610-617
998.
BackgroundTo assess the predictive value of 18F-fluorodeoxyglucose positron-emission tomography (FDG–PET/CT) in detecting mediastinal lymph node metastasis with histopathologic verification in breast cancer (BC) patients.Materials and methodsBetween February 2012 and October 2019, 37 BC patients who underwent histopathological verification for FDG-PET positive mediastinal lymph nodes were retrospectively analyzed. Nine patients (24%) were screened before beginning treatment, while 27 (76%) were screened at the time of disease progression, an average of 39 months after completion of initial treatment.ResultsThe histopathologic diagnosis revealed lymph node metastasis from BC in 15 patients (40%) and benign disease in 22 patients (60%). The standardized uptake value (SUVmax) of mediastinal lymph nodes was significantly higher in patients with lymph node metastasis compared to those with benign histology (9.0 ± 3.5 vs. 5.9 ± 2.4; P = 0.007). The cut-off value of SUVmax after the ROC curve analysis for pathological lymph node metastasis was 6.4. Two of the 15 patients with mediastinal SUVmax ≤ 6.4 and 13 of the 22 patients with SUVmax > 6.4 had lymph node metastasis. Age and pathological findings were prognostic factors for overall survival in univariate analysis. The treatment decision was changed in 19 patients (51%) after mediastinoscopic evaluation of the entire cohort.ConclusionsThis is the first study to support the need for pathologic confirmation of a positive PET/CT result following evaluation of mediastinal lymph nodes for staging BC, either at initial diagnosis or at the time of progression. Treatment decisions were consequently altered for nearly half of the patients. 相似文献
999.
PurposeTo compare the sensitivity for breast cancer (BC) and BC size estimation of preoperative contrast-enhanced magnetic resonance imaging (CEMRI) versus combined unenhanced magnetic resonance imaging (UMRI) and digital breast tomosynthesis (DBT).Patients and methodsWe retrospectively included 56 women who underwent DBT and preoperative 1.5 T CEMRI between January 2016–February 2017. Three readers with 2–10 years of experience in CEMRI and DBT, blinded to pathology, independently reviewed CEMRI (diffusion-weighted imaging [DWI], T2-weighted imaging, pre- and post-contrast T1-weighted imaging) and a combination of UMRI (DWI and pre-contrast T1-weighted imaging) and DBT. We calculated per-lesion sensitivity of CEMRI and UMRI + DBT, and the agreement between CEMRI, UMRI and DBT versus pathology in assessing cancer size (Bland-Altman analysis). Logistic regression was performed to assess features predictive of cancer missing.ResultsWe included 70 lesions (64% invasive BC, 36% ductal carcinoma in situ or invasive BC with in situ component). UMRI + DBT showed lower sensitivity (86–89%) than CEMRI (94–100%), with a significant difference for the most experienced reader only (p = 0.008). False-positives were fewer with UMRI + DBT (4–5) than with CEMRI (18–25), regardless of the reader (p = 0.001–0.005). For lesion size, UMRI showed closer limits of agreement with pathology than CEMRI or DBT. Cancer size ≤1 cm was the only independent predictor for cancer missing for both imaging strategies (Odds ratio 8.62 for CEMRI and 19.16 for UMRI + DBT).ConclusionsUMRI + DBT showed comparable sensitivity and less false-positives than CEMRI in the preoperative assessment of BC. UMRI was the most accurate tool to assess cancer size. 相似文献
1000.
目的探讨食管胃结合部腺癌(adenocarcinoma of esophagogastric junction,AEG)的No.4d、5、6、12组淋巴结转移的规律和相关因素。方法回顾2015年6月至2018年5月北京大学肿瘤医院胃肠肿瘤中心一病区行全胃切除的AEG病人的临床及病理资料,分析胃下部淋巴引流区域淋巴结即No.4d、5、6、12组淋巴结的转移率,并分析各临床病理因素与其相关性,计数资料的组间比较采用χ^2检验,计量资料的组间比较采用两独立样本t检验。结果该研究共纳入77例病人,其中48例(62.33%)合并淋巴结转移,转移率较高的为No.3、1、7组淋巴结,分别为43.42%、22.08%、22.08%。No.4d、5、6、12组的淋巴结转移率分别为5.26%、3.90%、1.30%、1.37%,胃下部淋巴引流区域淋巴结整体的转移率为9.09%。对各临床病理因素的分析结果显示,仅病理T分期与胃下部淋巴引流区域淋巴结转移相关。结论单中心回顾性数据显示,AEG病人胃下部淋巴引流区域淋巴结整体转移率为9.09%,pT 4期为胃下部淋巴引流区域淋巴结转移的高危因素。 相似文献